MARKET WIRE NEWS

Adaptive Biotechnologies Corporation (ADPT) Q2 2025 Earnings Call Transcript

Source: SeekingAlpha

2025-08-06 02:13:34 ET

Adaptive Biotechnologies Corporation (ADPT)

Q2 2025 Earnings Conference Call

August 05, 2025, 04:30 PM ET

Company Participants

Chad M. Robins - Co-Founder, CEO & Chairman

Karina Calzadilla - Vice President of Investor Relations

Kyle Piskel - VP, CFO & Principal Accounting Officer

Susan Bobulsky - Chief Commercial Officer of MRD

Conference Call Participants

Andrew Frederick Brackmann - William Blair & Company L.L.C., Research Division

Daniel Gregory Brennan - TD Cowen, Research Division

David Michael Westenberg - Piper Sandler & Co., Research Division

Mark Anthony Massaro - BTIG, LLC, Research Division

Sebastian L. Sandler - JPMorgan Chase & Co, Research Division

Yuko Oku - Morgan Stanley, Research Division

Presentation

Operator

Good day, and thank you for standing by. Welcome to the Adaptive Biotechnologies Second Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded....

Read the full article on Seeking Alpha

For further details see:

Adaptive Biotechnologies Corporation (ADPT) Q2 2025 Earnings Call Transcript
Adaptive Biotechnologies Corporation

NASDAQ: ADPT

ADPT Trading

3.65% G/L:

$12.915 Last:

1,468,501 Volume:

$13.05 Open:

mwn-alerts Ad 300

ADPT Latest News

February 05, 2026 09:07:36 pm
Adaptive Biotech (ADPT) Earnings Call Transcript

ADPT Stock Data

$2,393,790,148
142,894,616
2.45%
99
N/A
Biotechnology & Life Sciences
Healthcare
US
Seattle

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App